Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Intangibles: 2013-2024

Historic Intangibles for Amphastar Pharmaceuticals (AMPH) over the last 1 years, with Dec 2024 value amounting to $29.2 million.

  • Amphastar Pharmaceuticals' Intangibles changed negligibly% to $29.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $29.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $29.2 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q4 2024, Amphastar Pharmaceuticals' Intangibles is $29.2 million, which was down 0.00% from $29.2 million recorded in Q4 2023.
  • In the past 5 years, Amphastar Pharmaceuticals' Intangibles registered a high of $29.2 million during Q4 2020, and its lowest value of $29.2 million during Q4 2020.
  • For the 3-year period, Amphastar Pharmaceuticals' Intangibles averaged around $29.2 million, with its median value being $29.2 million (2024).